Vertex Pharmaceuticals Incorporated
Crystalline forms and compositions of CFTR modulators
Last updated:
Abstract:
Crystalline Forms of Compound I: ##STR00001## and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
Status:
Grant
Type:
Utility
Filling date:
19 Oct 2018
Issue date:
19 May 2020